The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients

Patients after organ transplantation have impaired immune response after vaccination against the SARS-CoV-2 virus. So far, published studies have reported quite different response rates to SARS-CoV-2 vaccination, ranging from 15–79% in liver and kidney transplant recipients. Up to one year after the...

Full description

Bibliographic Details
Main Authors: Anja Lautem, Simone Cosima Boedecker-Lips, Elisa Schneider, Stefan Runkel, Christina Feist, Hauke Lang, Julia Weinmann-Menke, Martina Koch
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Pathogens
Subjects:
SARS-CoV-2
transplantation
immunosuppression
immune response
vaccination
Online Access:https://www.mdpi.com/2076-0817/12/7/910

Internet

https://www.mdpi.com/2076-0817/12/7/910

Similar Items